Search Results - Jason E. Cummings
- Showing 1 - 4 results of 4
-
1
Epetraborole, a leucyl-tRNA synthetase inhibitor, demonstrates murine efficacy, enhancing the in vivo activity of ceftazidime against Burkholderia pseudomallei, the causative agent... by Jason E Cummings, Christopher S Lunde, M R K Alley, Richard A Slayden
Published in PLoS Neglected Tropical Diseases (2023-11-01)Get full text
Article -
2
Establishing translational performance standards for TB therapy using rifampicin-based regimens in a male and female high-burden murine model by Jason E. Cummings, Lisa Woolhiser, Barbara Graham, Gregory T. Robertson, M. Nurul Islam, Richard A. Slayden
Published in BMC Microbiology (2025-07-01)Get full text
Article -
3
Targeting intracellular nontuberculous mycobacteria and M. tuberculosis with a bactericidal enzymatic cocktail by Helen P. Bartlett, Clinton C. Dawson, Cody M. Glickman, David W. Osborn, Christopher R. Evans, Benjamin J. Garcia, Lauren C. Frost, Jason E. Cummings, Nicholas Whittel, Richard A. Slayden, Jason W. Holder
Published in Microbiology Spectrum (2024-05-01)Get full text
Article -
4
Evaluating the efficacy of HRZE-based regimens in a high-burden murine model: a back-translational assessment of rifamycins and moxifloxacin substitutions in tuberculosis treatment by Jason E. Cummings, Lisa K. Woolhiser, Vincent Guglielmi, Machenzie Wernsman, Ashley Romano, Samantha Pauly, Samantha Pauly, John T. Belisle, Nicholas D. Walter, Nicholas D. Walter, Nicholas D. Walter, Gregory T. Robertson, Gregory T. Robertson, Richard A. Slayden
Published in Frontiers in Pharmacology (2025-09-01)Get full text
Article
